Batch-Specific Lab Reports & COAs
At Kynetide, transparency is non-negotiable. Every research peptide batch undergoes independent third-party testing via High-Performance Liquid Chromatography (HPLC) for purity and Mass Spectrometry (MS) for identity. Below are the latest Certificates of Analysis. We update these regularly as new lots arrive.
Current Batches (Updated June 2026)
Retatrutide 30mg — Lot #RET-26031501 | Purity: 99.2% HPLC | Tested Mar 15, 2026 | View COA
Tirzepatide 40mg — Lot #TIR-26040901 | Purity: 99.3% HPLC | Tested Apr 09, 2026 | View COA
BPC-157 10mg — Lot #26031801-03 | Purity: 99.7% HPLC | Tested Mar 18, 2026 | View COA
Epithalon 10mg — Lot #EPI-26040201 | Purity: 99.6% HPLC | Tested Apr 02, 2026 | View COA
Ipamorelin 10mg — Lot #800046-26031501-04 | Purity: 99.8% HPLC | Tested Mar 15, 2026 | View COA
MOTS-c 40mg — Lot #MOT-26040401 | Purity: 99.0% HPLC | Tested Apr 04, 2026 | View COA
GHK-Cu 100mg — Lot #GHK-26040301 | Purity: 99.1% HPLC | Tested Apr 03, 2026 | View COA
Selank 10mg — Lot #26010501-01 | Purity: 99.8% HPLC | Tested Jan 28, 2026 | View COA
Research Use Only
All products are for laboratory research use only. COAs are provided for verification and documentation purposes.
